By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Affimed Therapeutics AG 

Technologiepark
Im Neuenheimer Feld 582
Heidelberg    69120   Germany
Phone: 49-6221-65307-0 Fax: 49-6221-65307-77


SEARCH JOBS


Industry
Biotechnology






Company News
Affimed Therapeutics AG (AFMD) Announces Financial Results For Fourth Quarter And Year End 2014 3/25/2015 7:50:15 AM
Affimed Therapeutics AG (AFMD) Completes Tandab Development Candidate Activities Meeting Amphivena's And Janssen Biotech Inc. (JNJ)'s Criteria And Achieves Milestone Ahead Of Schedule 3/24/2015 7:22:57 AM
Affimed Therapeutics AG (AFMD) Announces Fourth Quarter And Year End 2014 Financial Results Conference Call 3/18/2015 7:38:15 AM
Affimed Therapeutics AG (AFMD) To Present At The 27th Annual ROTH Conference 3/3/2015 8:31:01 AM
Affimed Therapeutics AG (AFMD) To Present At The BIO CEO & Investor Conference And At The Leerink Partners Global Healthcare Conference 2/3/2015 8:36:44 AM
Affimed Therapeutics AG (AFMD) Appoints Dr. Martin Treder As Chief Scientific Officer 1/20/2015 7:32:44 AM
Affimed Therapeutics AG (AFMD) Receives EUR 2.4 Million ($3 Million) Research Grant From German Government To Fund Trispecific Abs 1/7/2015 7:56:28 AM
Affimed Therapeutics AG (AFMD) Presents Final Data For AFM13 Phase 1 Trial At American Society of Hematology 12/8/2014 8:06:44 AM
Affimed Therapeutics AG (AFMD) To Present At The Jefferies and Co. Global Healthcare Conference - London 11/12/2014 10:10:57 AM
Affimed Therapeutics AG (AFMD) Announces Third Quarter 2014 Financial Results Conference Call 11/11/2014 8:44:42 AM
1234
//-->